Odonate Therapeutics, Inc.
ODTC · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $7,325 | $42,940 | -$68,315 | -$126,350 |
| Dep. & Amort. | $21 | $342 | $1,051 | $445 |
| Deferred Tax | $1,903 | -$33,314 | $0 | $83 |
| Stock-Based Comp. | $0 | $182 | $4,184 | $9,828 |
| Change in WC | -$606 | -$9,358 | -$14,715 | $2,439 |
| Other Non-Cash | $97 | $1,003 | $2,070 | $425 |
| Operating Cash Flow | $8,740 | $1,795 | -$75,725 | -$113,130 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$26 | -$432 |
| Net Acquisitions | $0 | $54 | $0 | $0 |
| Inv. Purchases | -$17,250 | -$58,399 | $0 | $0 |
| Inv. Sales/Matur. | $37,400 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $20,150 | -$58,345 | -$26 | -$432 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $825 | $87,383 |
| Stock Repurch. | $0 | -$1,620 | -$13,575 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$196 | $0 | $0 | $2,984 |
| Financing Cash Flow | -$196 | -$1,620 | -$12,750 | $90,367 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $28,822 | -$58,170 | -$88,373 | -$23,195 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,722 | $68,892 | $157,265 | $181,174 |
| End Cash | $39,544 | $10,722 | $68,892 | $157,979 |
| Free Cash Flow | $8,740 | $1,795 | -$75,751 | -$113,562 |